Arrowhead Pharmaceuticals's quarterly market cap
declined
from Jun. 2023 ($3,819.3 Mil) to Sep. 2023 ($2,883.5 Mil) but then
increased
from Sep. 2023 ($2,883.5 Mil) to Dec. 2023 ($3,289.5 Mil).
Arrowhead Pharmaceuticals's annual market cap
declined
from Sep. 2021 ($6,513.1 Mil) to Sep. 2022 ($3,502.0 Mil) and
declined
from Sep. 2022 ($3,502.0 Mil) to Sep. 2023 ($2,883.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Arrowhead Pharmaceuticals's Enterprise Value for Today is $2,607.9 Mil.
Arrowhead Pharmaceuticals Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arrowhead Pharmaceuticals's Market Cap
For the Biotechnology subindustry, Arrowhead Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arrowhead Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arrowhead Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Arrowhead Pharmaceuticals's Market Cap falls into.
Arrowhead Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arrowhead Pharmaceuticals (NAS:ARWR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Arrowhead Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Arrowhead Pharmaceuticals (Arrowhead Pharmaceuticals) Business Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARWR has been successfully added to your 